Navigation Links
Remedy Informatics to Partner with Nemours Center for Cancer and Blood Disorders on Development of First-Ever Pediatric Oncology Registry

SALT LAKE CITY, Dec. 18, 2013 /PRNewswire/ -- Remedy Informatics, the leading provider of registry-based clinical informatics software for healthcare delivery and life sciences research, announced that it will partner with researchers at the Nemours Center for Cancer and Blood Disorders at the Alfred I. duPont Hospital for Children to build the first-ever oncology registry designed specifically for pediatric cancer research.


"The opportunity to work with an organization like Nemours is really quite exciting and moving," said Gary Kennedy, Founder & CEO of Remedy Informatics. "We are always looking to collaborate with leading minds and organizations. Nemours is a recognized leader in pediatric oncology research, and the expertise and knowledge they bring to this project will be invaluable. As a father and grandfather, this project certainly has special meaning to me because the focus is on finding cures and improved treatments for children impacted by cancer."

Remedy has developed a number of oncology-focused registries for other clients that will serve as the basis for this collaboration. All of Remedy's registries are built on its flagship Mosaic™ Platform, which offers the industry's most advanced clinical informatics solution. The Mosaic Platform delivers highly configurable, user-friendly registries that are designed to evolve with an organization's changing research needs without intervention from IT departments or outside technology consultants. The Mosaic Platform will enable researchers at the Nemours Center for Cancer and Blood Disorders to rapidly broaden their impact on quality cancer care and allow clinical researchers to gain a 360-degree view of their research data. Clinical researchers and oncologists will then be able to analyze the data using powerful pattern recognition and data visualization tools to further their efforts to improve quality of care.

"Our commitment to deliver the best possible care to our young patients means we are always looking for innovative and effective solutions," said E. Anders Kolb, MD, Hematology/Oncology Division Chief at duPont Hospital for Children. "Our pediatric transplant group has had a positive relationship with Remedy Informatics, and after further investigation we could see that their registry technology was the right fit for our pediatric oncology registry project."

Earlier this year, the Nemours Center for Cancer and Blood Disorders received a two-year, $1.2 million grant from the National Cancer Institute (NCI) of the National Institutes of Health (NIH) to establish the Nemours Community Clinical Oncology Program (CCOP), only the second of its kind in the United States. The goal of the consortium is to bring together four Nemours sites and several cancer investigators in an integrated pediatric cancer network.

According to Dr. Kolb, this collaborative nature of the CCOP is one of its strengths, and "Remedy Informatics' platform-based approach makes sharing the data and findings between our institutions and researchers, spread across the country, much easier than we could have imagined. I believe this increased ability to share information will lead our researchers to make discoveries and develop new cancer treatments more quickly."

The project will also be funded by a Hope on Wheels® 2013 Hyundai Scholar Grant. Recipients, known as Hyundai Scholars, receive grants to pursue research and clinical programs aimed at improving the lives of children battling pediatric cancer.

"Our goal is to allow Nemours' researchers to focus on discovery without having to worry about or be hindered by technology. Our registry will help Nemours make new discoveries and provide more hope for those patients and their families affected by cancer," said Kennedy.

For more information about Remedy's leading registry-based clinical informatics technology, or to request a demonstration, please visit our website,

About Nemours
Nemours is an internationally recognized children's health system that owns and operates the Nemours/Alfred I. duPont Hospital for Children in Wilmington, Del., and Nemours Children's Hospital in Orlando, along with major pediatric specialty clinics in Delaware, Florida, Pennsylvania and New Jersey.

Established as The Nemours Foundation through the legacy and philanthropy of Alfred I. duPont, Nemours offers pediatric clinical care, research, education, advocacy and prevention programs to all families in the communities it serves.

About Remedy Informatics, Inc.
Founded in 2003, Remedy Informatics, Inc. is a leading provider of registry-based oncology, cardiovascular and other informatics software products for life sciences research and healthcare delivery. The company, whose mission is to tangibly, measurably and permanently improve life sciences research and healthcare delivery around the world, serves a wide range of leading life sciences, translational research and healthcare institutions globally, including the Cleveland Clinic, Massachusetts General Hospital, Baylor Health Care System and many more. Built on the innovative Mosaic™ Platform, all of Remedy's products are configurable and user-friendly. For more information visit:

Media Contacts

Kristofer Beldin, Remedy Informatics, (801) 733-3335 (office)/(801) 870-9407 (cell),

SOURCE Remedy Informatics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Natural Acne Remedy, Probiotic Action Shares New Tips on Eating for Healthy Skin
2. Natural Acne Remedy, Probiotic Action, Shares New Industry Insight on Using Household Products as Acne Treatments
3. Natural Acne Remedy Maker Offers Potential Symptom Relief for Psoriasis Patients
4. Natural Acne Remedy, Probiotic Action Offers Ways to Treat Acne During Pregnancy
5. Natural Acne Remedy, Probiotic Action Debunks Makeup Removing Myths
6. Natural Acne Remedy Offers Skin care Advice for Expectant, and New Mothers
7. Natural Acne Remedy, Probiotic Action, Announces the Unveiling of their New Probiotic Acne Cleanser
8. Natural Acne Remedy, Probiotic Action Explains New Information On Why More Children Are Diagnosed Acne
9. Natural Acne Remedy, Probiotic Action Shares New Insight Behind Why Some Acne Treatments May Not Work for All Skin Types
10. Natural Acne Remedy, Probiotic Action Shares Industry Insight on the Correlation between Processed Foods and Acne
11. Natural Acne Remedy, Probiotic Action Sheds Industry Insight on the Connection between Dairy and Acne
Post Your Comments:
(Date:11/25/2015)... November 26, 2015 ... Market 2016 - 2020 report analyzes that automating ... and quality in long-term samples, minimizing manual errors, ... Automation minimizes manual errors such as mislabeling or ... Further, it plays a vital role in blood ...
(Date:11/25/2015)... Studies reveal the differences in ... pave the way for more effective treatment for one of ...   --> --> Gum ... in cats, yet relatively little was understood about the bacteria ... been conducted by researchers from the WALTHAM Centre for Pet ...
(Date:11/25/2015)... QUEBEC CITY , Nov. 25, 2015 /PRNewswire/ ... "Company"), affirms that its business and prospects remain ... , Zoptrex™ (zoptarelin doxorubicin) recently received DSMB ... program to completion following review of the final ... met Phase 2 Primary Endpoint in men with ...
(Date:11/25/2015)... , November 25, 2015 ... Report is a professional and in-depth study on ...      (Logo: ) , ... the industry including definitions, classifications, applications and industry ... for the international markets including development trends, competitive ...
Breaking Biology Technology:
(Date:11/19/2015)... 2015  Although some 350 companies are actively involved ... few companies, according to Kalorama Information. These include Roche Diagnostics, ... market share of the 6.1 billion-dollar molecular testing market, ... for Molecular Diagnostic s .    ... controlled by one company and only a handful of ...
(Date:11/17/2015)... , Nov. 17, 2015  Vigilant Solutions announces ... joined its Board of Directors. --> ... after recently retiring from the partnership at TPG Capital, ... companies with over $140 Billion in revenue.  He founded ... across all the TPG companies, from 1997 to 2013.  ...
(Date:11/12/2015)... 11, 2015   Growing need for low-cost, ... has been paving the way for use of ... discrete analytes in clinical, agricultural, environmental, food and ... used in medical applications, however, their adoption is ... to continuous emphasis on improving product quality and ...
Breaking Biology News(10 mins):